Trial Profile
The Effect of GLP-1 on the Inhibition of Glucagon Secretion.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Glucagon-like peptide-1 7-36 amide (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Aug 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jan 2012 New trial record